Jamie H Thompson
Overview
Explore the profile of Jamie H Thompson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
475
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Thompson J, Rivelli J, Schneider J, Kenzie E, Myers E, Coury J, et al.
J Eval Clin Pract
. 2024 Jun;
30(7):1457-1466.
PMID: 38935862
Purpose: Patient navigation is a recommended practice to improve cancer screenings among underserved populations including those residing in rural areas with care access barriers. We report on patient navigation programme...
2.
Gautom P, Rosales A, Petrik A, Thompson J, Slaughter M, Mosso L, et al.
Cancer Prev Res (Phila)
. 2024 Apr;
17(7):325-333.
PMID: 38641422
Patient navigation (PN) has been shown to improve participation in cancer screening, including colorectal cancer screening, and is now a recommended practice by the Community Preventive Services Task Force. Despite...
3.
Coronado G, Nyongesa D, Petrik A, Thompson J, Escaron A, Pham T, et al.
Cancer Epidemiol Biomarkers Prev
. 2024 Feb;
33(4):525-533.
PMID: 38319289
Background: Mailed fecal immunochemical test (FIT) outreach can improve colorectal cancer screening participation. We assessed the reach and effectiveness of adding notifications to mailed FIT programs. Methods: We conducted secondary...
4.
Thompson J, Rivelli J, Escaron A, Garcia J, Ruiz E, Torres-Ozadali E, et al.
Hisp Health Care Int
. 2023 Nov;
22(4):216-224.
PMID: 37936370
Colorectal cancer (CRC) is a leading cause of cancer death in the US. Screening by fecal immunochemical test (FIT) is a strategy to lower CRC rates. Unfortunately, only half of...
5.
Coronado G, Nyongesa D, Escaron A, Petrik A, Thompson J, Smith D, et al.
Cancer Epidemiol Biomarkers Prev
. 2023 Aug;
32(11):1608-1616.
PMID: 37566431
Background: Mailed fecal immunochemical test (FIT) outreach can improve colorectal cancer screening rates, yet little is known about how to optimize these programs for effectiveness and cost. Methods: PROMPT was...
6.
Coronado G, Ruiz E, Torres-Ozadali E, Thompson J, Rivelli J, Thibault A, et al.
PLOS Digit Health
. 2023 May;
2(5):e0000258.
PMID: 37253020
No abstract available.
7.
Gautom P, Escaron A, Garcia J, Thompson J, Rivelli J, Ruiz E, et al.
BMC Gastroenterol
. 2023 May;
23(1):179.
PMID: 37221503
Introduction: In partnership with a federally qualified health center (FQHC), an adapted virtual version of boot camp translation (BCT) was used to elicit input from Spanish-speaking Latino patients and staff...
8.
Schneider J, Rivelli J, Vaughn K, Thompson J, Petrik A, Escaron A, et al.
Transl Behav Med
. 2023 May;
13(10):757-767.
PMID: 37210075
Colorectal cancer (CRC) is a leading cause of cancer death in the USA. Screening programs in federally qualified health centers (FQHCs) are essential to reducing CRC-related mortality and morbidity among...
9.
Coronado G, Ferrari R, Barnes A, Castaneda S, Cromo M, Davis M, et al.
J Natl Cancer Inst
. 2023 Feb;
115(6):680-694.
PMID: 36810931
Background: Although patient navigation has shown promise for increasing participation in colorectal cancer screening and follow-up, little evidence is available to guide implementation of patient navigation in clinical practice. We...
10.
Escaron A, Garcia J, Petrik A, Ruiz E, Nyongesa D, Thompson J, et al.
J Prim Care Community Health
. 2022 Nov;
13:21501319221138423.
PMID: 36448466
Objective: Individuals with an abnormal fecal immunochemical test (FIT) result have an elevated risk of colorectal cancer, and the risk increases if the follow-up colonoscopy is delayed. Of note, rates...